State Stem Cell Agency Standards Working Group Agenda 12/1/05

Return to CIRM Meetings and Events

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

California State Stem Cell Agency

 

Regular Meeting 12-01-05

SCIENTIFIC & MEDICAL ACCOUNTABILITY STANDARDS WORKING GROUP
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT
 

Date: December 1, 2005

Time: 10:00 AM – 6:00 PM

Location:

  • Moscone Center South
    747 Howard St
    San Francisco, CA
    Room: 250-260
 

PUBLIC SESSION

  1. Welcome and Introduction of New Members
  2. Call to Order
  1. Roll Call.

CONSENT ITEMS

  1. Approval of Meeting Minutes from October 24, 2005

REGULAR ITEMS

  1. CIRM Staff Update
    1. IP Task Force Progress Report
    2. CIRM Grants Administration Policy Report
  1. Review of CIRM Draft Regulations language Draft Regulations
    1. Overview
    2. Summary of Working Group Comments and Revisions
    3. Section 100001: Definitions
    4. Sections 100003-5: ESCRO requirements
    5. Section 100008: Banking
  1. Issues to be considered at this meeting of the Standards Working Group include but are not limited to:
    1. Consideration of Informed Consent Requirements (Section 100007) Working Notes: Informed Consent
    2. Consideration of “Ethically Derived” (Section 100006)
    3. Public Comment Summary
  1. Consideration of Work Plan to Develop Final Draft Regulations
    1. Timeline
  2. Other business
  1. Adjournment

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.
 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at (415) 396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Scientific and Medical Research Funding Working Group meeting may be referred to Pat Beaupre Becker at the California Institute for Regenerative Medicine at pbecker@cirm.ca.gov or (415) 396-9105.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.

 

Transcripts

Date Published: April 7, 2009
Last Modified: April 5, 2017